|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-10-24
|
|
pubmed:abstractText |
Anaemia is common in cancer patients treated with chemotherapy. Darbepoetin alfa (DA) is the only erythropoiesis-stimulating protein approved for administration at weekly and every-three-week intervals in cancer patients receiving chemotherapy. This article investigates the effectiveness, tolerability and effect on fatigue of DA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
pubmed-author:AMG-DAR-2002-01 Study Group,
pubmed-author:AlegreAA,
pubmed-author:CassinelloJJ,
pubmed-author:GasquetJ AJA,
pubmed-author:GonzálezAA,
pubmed-author:LewK KKK,
pubmed-author:MontesinosJJ,
pubmed-author:RodríguezC ACA,
pubmed-author:SánchezJJ,
pubmed-author:SaigíEE,
pubmed-author:SalarAA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2931-42
|
|
pubmed:meshHeading |
pubmed-meshheading:18775103-Adult,
pubmed-meshheading:18775103-Aged,
pubmed-meshheading:18775103-Aged, 80 and over,
pubmed-meshheading:18775103-Anemia,
pubmed-meshheading:18775103-Antineoplastic Agents,
pubmed-meshheading:18775103-Erythropoiesis,
pubmed-meshheading:18775103-Erythropoietin,
pubmed-meshheading:18775103-Fatigue,
pubmed-meshheading:18775103-Female,
pubmed-meshheading:18775103-Hematinics,
pubmed-meshheading:18775103-Hemoglobins,
pubmed-meshheading:18775103-Humans,
pubmed-meshheading:18775103-Male,
pubmed-meshheading:18775103-Middle Aged,
pubmed-meshheading:18775103-Neoplasms,
pubmed-meshheading:18775103-Time Factors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia.
|
|
pubmed:affiliation |
Complexo Hospitalario Xeral-Calde, Severo Ochoa, s/n, 27004 Lugo, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
